(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | 14.46%2.26B | ---- | ---- | ---- | -6.54%1.98B | ---- | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | -35.92%-109.17M | ---- | ---- | ---- | 5.17%-80.32M | ---- | ---- |
Interest expense - adjustment | ---- | ---- | ---- | -6.85%213.63M | ---- | ---- | ---- | -10.00%229.33M | ---- | ---- |
Dividend (income)- adjustment | ---- | ---- | ---- | -75.70%-49.83M | ---- | ---- | ---- | 58.03%-28.36M | ---- | ---- |
Investment loss (gain) | ---- | ---- | ---- | 11.68%-8.6M | ---- | ---- | ---- | -10,914.44%-9.73M | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | 211.90%393K | ---- | ---- | ---- | 108.94%126K | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | -62.71%393K | ---- | ---- | ---- | -90.16%1.05M | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 92.23%-928K | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | 17,812.54%108.76M | ---- | ---- | ---- | 98.56%-614K | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | 17,812.54%108.76M | ---- | ---- | ---- | 98.56%-614K | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | 179.10%6.67M | ---- | ---- | ---- | -196.82%-8.43M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 4,445.27%6.43M | ---- | ---- | ---- | -105.22%-148K | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | 102.90%240K | ---- | ---- | ---- | -240.99%-8.29M | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | -2.21%924.5M | ---- | ---- | ---- | 1.24%945.36M | ---- | ---- |
-Depreciation | ---- | ---- | ---- | -9.70%149.48M | ---- | ---- | ---- | -2.29%165.54M | ---- | ---- |
-Amortization of intangible assets | ---- | ---- | ---- | -0.57%756.75M | ---- | ---- | ---- | 2.45%761.11M | ---- | ---- |
Special items | ---- | ---- | ---- | --3.48M | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | 10.86%3.35B | ---- | ---- | ---- | -2.95%3.03B | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | -64.01%248K | ---- | ---- | ---- | -59.99%689K | ---- | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | 83.96%-49.47M | ---- | ---- | ---- | 33.85%-308.51M | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | -17.45%-77.23M | ---- | ---- | ---- | 68.51%-65.76M | ---- | ---- |
Special items for working capital changes | ---- | ---- | ---- | -37.43%-9.4M | ---- | ---- | ---- | 90.24%-6.84M | ---- | ---- |
Cash from business operations | ---- | -1.47%1.67B | ---- | 21.67%3.22B | ---- | 12.95%1.7B | ---- | 11.42%2.64B | ---- | 30.19%1.5B |
Other taxs | ---- | 2.47%-274.85M | ---- | 19.36%-584.37M | ---- | 32.90%-281.81M | ---- | -14.68%-724.64M | ---- | -1.49%-420M |
Interest paid - operating | ---- | -0.21%-114.46M | ---- | 3.00%-233.36M | ---- | -1.56%-114.22M | ---- | -74.07%-240.58M | ---- | -82.30%-112.47M |
Adjustment items of business operations | -6.19%2.11B | ---- | -34.52%674.13M | ---- | 27.04%2.25B | ---- | 93.23%1.03B | ---- | 6.34%1.77B | ---- |
Net cash from operations | -6.19%2.11B | -1.40%1.28B | -34.52%674.13M | 42.90%2.4B | 27.04%2.25B | 34.09%1.3B | 93.23%1.03B | 4.74%1.68B | 6.34%1.77B | 42.93%971.61M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 547.69%71.47M | ---- | -44.55%28.25M | ---- | -6.29%11.04M | ---- | -7.85%50.95M | ---- | -48.34%11.78M |
Dividend received - investment | -36.81%27.06M | --14.59M | --7.39M | 28.63%49.83M | 35.22%42.82M | ---- | ---- | -32.27%38.74M | 4.62%31.67M | -2.30%23.67M |
Restricted cash (increase) decrease | ---- | 161.91%486M | ---- | -28.21%-1.08B | ---- | -57.00%-785M | ---- | -38.61%-840M | ---- | -455.67%-500M |
Sale of fixed assets | -68.51%970.89K | 3.86%808K | 96.30%72K | -71.88%3.78M | 143.64%3.08M | -1.52%778K | -93.75%36.68K | -1.34%13.44M | -86.88%1.27M | -92.90%790K |
Purchase of fixed assets | -15.84%-662.4M | -276.74%-7.97M | -220.34%-313.98M | 33.73%-116.33M | 53.39%-571.82M | 91.16%-2.12M | -83.39%-98.02M | -163.97%-175.55M | -410.21%-1.23B | -640.64%-23.93M |
Purchase of intangible assets | ---- | 32.37%-317.49M | ---- | -75.39%-2B | ---- | 55.07%-469.48M | ---- | -342,372.67%-1.14B | ---- | -1,393,006.67%-1.04B |
Recovery of cash from investments | -20.00%2.66M | -97.45%2.66M | --2.66M | -75.65%227.18M | -95.65%3.32M | 36.31%104.11M | ---- | -77.44%932.88M | --76.38M | -97.56%76.38M |
Cash on investment | 68.68%-16.64M | 89.13%-16.64M | 50.49%-16.44M | 84.09%-213.13M | 0.00%-53.13M | -361.13%-153.13M | -0.00%-33.21M | 55.83%-1.34B | -60.00%-53.13M | 98.67%-33.21M |
Other items in the investment business | 136.71%339.93M | ---- | 121.68%181.04M | ---- | 39.90%-925.88M | ---- | -4,219.94%-835M | ---- | -1,051.01%-1.54B | ---- |
Net cash from investment operations | 79.46%-308.43M | 118.04%233.42M | 85.59%-139.27M | -25.93%-3.1B | 44.62%-1.5B | 13.13%-1.29B | 11.77%-966.19M | -542.70%-2.46B | -3,678.61%-2.71B | -351.49%-1.49B |
Net cash before financing | 141.22%1.8B | 16,669.89%1.52B | 745.33%534.86M | 10.59%-697.44M | 179.24%746.33M | 101.75%9.05M | 111.25%63.27M | -136.13%-780.09M | -159.16%-941.91M | -140.70%-517.75M |
Cash flow from financing activities | ||||||||||
New borrowing | 1,109.05%967.24M | 1,109.05%967.24M | 400.00%400M | -75.92%480M | -95.99%80M | -95.53%80M | -89.52%80M | -47.23%1.99B | 3.44%1.99B | 2.15%1.79B |
Refund | -287.25%-967.51M | -158.67%-579.51M | 71.68%-7.31M | -56.82%-652.07M | 11.55%-249.84M | 8.95%-224.03M | 65.60%-25.81M | 54.58%-415.81M | 71.56%-282.48M | 67.14%-246.06M |
Dividends paid - financing | 3.97%-1.18B | 81.95%-27.11M | 2.08%-58.94M | 4.58%-1.06B | 4.17%-1.23B | 25.36%-150.22M | -8.73%-60.19M | -125.10%-1.11B | -116.92%-1.28B | ---201.25M |
Absorb investment income | --72.29M | --34.67M | --7.56M | -99.05%10M | --0 | ---- | ---- | --1.05B | --1.04B | --444.84M |
Other items of the financing business | ---- | ---- | ---- | 98.36%-19.5M | ---- | 98.27%-19.5M | ---- | 62.08%-1.19B | ---1.12B | -371.63%-1.12B |
Net cash from financing operations | 20.80%-1.11B | 225.99%395.28M | 5,787.40%341.31M | -484.13%-1.24B | -498.69%-1.4B | -147.24%-313.75M | -100.74%-6M | 141.90%323.86M | 2.00%350.32M | -13.31%664.14M |
Effect of rate | --0 | -488.89%-35K | ---- | -103.64%-6K | --0 | --9K | ---- | 350.00%165K | --0 | ---- |
Net Cash | 206.73%694.15M | 727.93%1.91B | 1,429.87%876.18M | -325.54%-1.94B | -9.94%-650.38M | -308.13%-304.7M | -77.15%57.27M | -132.91%-456.24M | -130.56%-591.59M | -92.82%146.4M |
Begining period cash | -66.86%962.38M | -66.86%962.38M | -66.86%962.38M | -13.57%2.9B | -13.57%2.9B | -13.57%2.9B | -13.57%2.9B | 70.23%3.36B | 70.75%3.36B | 70.23%3.36B |
Cash at the end | -26.49%1.66B | 10.64%2.88B | -37.91%1.84B | -66.86%962.38M | -18.60%2.25B | -25.87%2.6B | -17.99%2.96B | -13.57%2.9B | -29.08%2.77B | -12.60%3.51B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data